14 Result(s)

Article

High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation

We evaluated high-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation. One hundred and seventy-four consecu...

R Nakamura, K Cortez, S Solomon, M Battiwalla, VJ Gill… in Bone Marrow Transplantation (2002)

Article

CMV reactivation in nonmyeloablative HSCT

C Graber, KNF de Almeider, R Childs, AJ Barrett, VJ Gill… in Bone Marrow Transplantation (2001)

Article

Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients

Viridans streptococci were the most common cause of bacteremia in 61 consecutive myeloablative allogeneic hematopoietic stem cell transplant (HSCT) recipients, occurring in 19 of 31 bacteremic patients (61%) d...

CJ Graber, KNF de Almeida, JC Atkinson, D Javaheri… in Bone Marrow Transplantation (2001)

Article

Donor leukocyte infusions for multiple myeloma

Donor leukocyte infusion (dli) has well-documented activity in cml, but the role of dli in other diseases is less well defined. to evaluate the strategy in multiple myeloma (mm) we evaluated 25 mm patients fro...

M Salama, T Nevill, D Marcellus, P Parker, M Johnson, A Kirk… in Bone Marrow Transplantation (2000)

Article

High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients

In a series of 74 patients with hematological malignancies undergoing allogeneic bone marrow or peri- pheral blood stem cell transplants from an HLA-identical sibling donor, four developed diffuse alveolar hem...

A Raptis, D Mavroudis, AF Suffredini, J Molldrem, F Van Rhee… in Bone Marrow Transplantation (1999)

Article

Circulating basic fibroblast growth factor declines during Cy/TBI bone marrow transplantation

Basic fibroblast growth factor (bFGF) inhibits radiation-induced apoptosis, and radioprotects haematopoietic, cartilage growth plate, pulmonary and gastrointestinal tissues. Conversely, chronic overexpression ...

P Okunieff, AJ Barrett, SE Phang, A Li, LS Constine… in Bone Marrow Transplantation (1999)

Article

A technique for dual determination of cytotoxic and helper lymphocyte precursor frequency by a miniaturized dye release method

Helper (HTLPf) and cytotoxic (CTLPf) lymphocyte precursor frequency assays are increasingly used in bone marrow stem cell and organ transplant compatibility testing. Current techniques require large cell numbe...

N Hensel, V Agarwala, Y-Z Jiang, D Mavroudis, J Molldrem… in Bone Marrow Transplantation (1999)

Article

High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine

Nine of 56 (20% actuarial) patients receiving a T cell-depleted, HLA-identical sibling BMT for hematological malignancy developed hemorrhagic cystitis (HC) 15–368 days post BMT. Hematuria was severe and prolon...

R Childs, C Sanchez, H Engler, J Preuss, S Rosenfeld… in Bone Marrow Transplantation (1998)

Article

Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia

Various isolation strategies are used to prevent infections during bone marrow transplantation; data on their efficacy are lacking. We studied whether use of high efficiency particulate air filtration (HEPA) a...

JR Passweg, PA Rowlings, KA Atkinson, AJ Barrett, RP Gale… in Bone Marrow Transplantation (1998)

Article

T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect

Thirty-eight patients with hematological malignancies, received T cell-depleted marrow transplants (BMT) and cyclosporine to prevent acute graft-versus-host disease (aGVHD), followed by delayed add-back of don...

AJ Barrett, D Mavroudis, J Tisdale, J Molldrem, E Clave… in Bone Marrow Transplantation (1998)

Article

T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34⁺ cell content but is associated with delayed pancytopenia

To increase the stem cell content of T cell-depleted bone marrow transplants (BMT), we treated 12 patients with hematological malignancies with BMT from HLA-identical sibling donors given G-CSF 10 μg/kg/day fo...

DA Mavroudis, EJ Read, J Molldrem, A Raptis, M Plante… in Bone Marrow Transplantation (1998)

Article

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

T and B lineage ALL cells express different levels of HLA-class II antigens, which may serve as targets for graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL). The object of this study was to det...

JR Passweg, P Tiberghien, J-Y Cahn, MR Vowels, BM Camitta… in Bone Marrow Transplantation (1998)

Article

Preferential usage of T cell receptor (TCR) V β by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease

New understanding of the alloresponse following bone marrow transplantation supports the possibility that the graft-versus-host disease (GVHD) response can be separated from a favorable graft-versus-leukemia (...

Y-Z Jiang, DA Mavroudis, S Dermime, J Molldrem, NF Hensel… in Bone Marrow Transplantation (1997)

Article

Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation

We studied patients relapsing with myeloid leukemias following allogeneic bone marrow transplantation (BMT) for evidence of immune escape by clonal evolution of the leukemia. Relapsed cells from four out of fi...

S Dermime, D Mavroudis, Y-Z Jiang, N Hensel, J Molldrem… in Bone Marrow Transplantation (1997)